BMB Reports : Impact Factor & More
eISSN: 1976-670XpISSN: 1976-6696
Open AccessShare this on:
Key Metrics
CiteScore 
7
Eigenfactor
0.005 - 0.01
Impact Factor
< 5
SJR
Q2Biochemistry
SNIP
1.05
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on BMB Reports
BMB Reports Journal Specifications
| Overview | |
| Publisher | KOREAN SOCIETY BIOCHEMISTRY & MOLECULAR BIOLOGY |
| Language | English |
| Frequency | Monthly |
| Article Processing Charges | USD 550 |
| Publication Time | 7 |
| Editorial Review Process | Peer review |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 2008 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Other charges | Visit website |
| Publication Time | 7 |
| Editorial Review Detail | |
| Information for authors |
View less
Planning to publish in BMB Reports ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in BMB Reports
Urolithin A improves mitochondrial dysfunction induced by oxidative stress in human dermal papilla cells.
- 24 Jun 2026
- BMB reports
Epigallocatechin gallate suppresses adipogenesis by targeting tetranectin and inhibiting its endocytosis via modulation of ERK and AKT signaling pathways.
- 24 Jun 2026
- BMB reports
Immunoproteasome inhibition protects the retina from Alzheimer's-associated degeneration.
- 24 Jun 2026
- BMB reports
Immune phenotype-based stratification of colorectal cancer reveals subtype-specific immunotherapeutic opportunities: insights from a Korean patient cohort.
- 2 Jun 2026
- BMB reports
Whole genome-based polygenic risk score and structural variation analysis in Korean patients with inflammatory bowel disease.
- 2 Jun 2026
- BMB reports
EK-16005, a 2-anilinopyrimidine derivative, inhibits breast cancer progression by regulating myeloid-derived suppressor cells.
- 2 Jun 2026
- BMB reports
Urolithin A improves mitochondrial dysfunction induced by oxidative stress in human dermal papilla cells.
- 24 Jun 2026
- BMB reports
Epigallocatechin gallate suppresses adipogenesis by targeting tetranectin and inhibiting its endocytosis via modulation of ERK and AKT signaling pathways.
- 24 Jun 2026
- BMB reports
Immunoproteasome inhibition protects the retina from Alzheimer's-associated degeneration.
- 24 Jun 2026
- BMB reports
Immune phenotype-based stratification of colorectal cancer reveals subtype-specific immunotherapeutic opportunities: insights from a Korean patient cohort.
- 2 Jun 2026
- BMB reports
Whole genome-based polygenic risk score and structural variation analysis in Korean patients with inflammatory bowel disease.
- 2 Jun 2026
- BMB reports
EK-16005, a 2-anilinopyrimidine derivative, inhibits breast cancer progression by regulating myeloid-derived suppressor cells.
- 2 Jun 2026
- BMB reports
FAQs on BMB Reports
How long has BMB Reports been actively publishing? 
What is the publishing frequency of BMB Reports?
How many articles did BMB Reports publish last year?
What is the eISSN & pISSN for BMB Reports?
What is Citescore for BMB Reports?
What is SNIP score for BMB Reports?
What is the SJR for BMB Reports?
Who is the publisher of BMB Reports?
